Earnings Per Share of Common Stock (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the reconciliations of the numerators and denominators of the Company’s basic and diluted earnings per share (“EPS”) calculations for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Net income attributable to Chemours	$	240	$	214	$	675	$	375
Denominator:
Weighted-average number of common shares outstanding - basic		155,376,422		165,113,024		157,149,738		165,627,861
Dilutive effect of the Company’s employee compensation plans		2,473,700		3,841,670		3,199,339		3,742,889
Weighted-average number of common shares outstanding - diluted		157,850,122		168,954,694		160,349,077		169,370,750
Basic earnings per share of common stock	$	1.54	$	1.30	$	4.30	$	2.26
Diluted earnings per share of common stock		1.52		1.27		4.21		2.21

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following table sets forth the average number of stock options that were anti-dilutive and, therefore, were not included in the Company’s diluted EPS calculations for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Average number of stock options		993,598		1,499,648		1,113,383		1,501,344